2015-2025 Global Drugs for Non-small Cell Lung Cancer Market Research by Type, End-Use and Region (COVID-19 Version)

2015-2025 Global Drugs for Non-small Cell Lung Cancer Market Research by Type, End-Use and Region (COVID-19 Version)

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Drugs for Non-small Cell Lung Cancer Production Forecast
Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Drugs for Non-small Cell Lung Cancer Forecast by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2025 (Volume)
8.3 Global Drugs for Non-small Cell Lung Cancer Forecast by End-Use (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Drugs for Non-small Cell Lung Cancer Forecast by Region (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by Region in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
9.1.2 Bristol-Myers Squibb Products & Services
9.1.3 Bristol-Myers Squibb Company Dynamics & News
9.1.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.2.2 GlaxoSmithKline Products & Services
9.2.3 GlaxoSmithKline Company Dynamics & News
9.2.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Menarini
9.3.1 Menarini Profile
Table Menarini Overview List
9.3.2 Menarini Products & Services
9.3.3 Menarini Company Dynamics & News
9.3.4 Menarini Business Operation Conditions
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sanofi
9.4.1 Sanofi Profile
Table Sanofi Overview List
9.4.2 Sanofi Products & Services
9.4.3 Sanofi Company Dynamics & News
9.4.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Ziopharm Oncology
9.5.1 Ziopharm Oncology Profile
Table Ziopharm Oncology Overview List
9.5.2 Ziopharm Oncology Products & Services
9.5.3 Ziopharm Oncology Company Dynamics & News
9.5.4 Ziopharm Oncology Business Operation Conditions
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Alchemia
9.6.1 Alchemia Profile
Table Alchemia Overview List
9.6.2 Alchemia Products & Services
9.6.3 Alchemia Company Dynamics & News
9.6.4 Alchemia Business Operation Conditions
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Amgen
9.7.1 Amgen Profile
Table Amgen Overview List
9.7.2 Amgen Products & Services
9.7.3 Amgen Company Dynamics & News
9.7.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Apotex
9.8.1 Apotex Profile
Table Apotex Overview List
9.8.2 Apotex Products & Services
9.8.3 Apotex Company Dynamics & News
9.8.4 Apotex Business Operation Conditions
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 BioMarin Pharmaceutical
9.9.1 BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Overview List
9.9.2 BioMarin Pharmaceutical Products & Services
9.9.3 BioMarin Pharmaceutical Company Dynamics & News
9.9.4 BioMarin Pharmaceutical Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 CellAct Pharma
9.10.1 CellAct Pharma Profile
Table CellAct Pharma Overview List
9.10.2 CellAct Pharma Products & Services
9.10.3 CellAct Pharma Company Dynamics & News
9.10.4 CellAct Pharma Business Operation Conditions
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Cerulean Pharma
9.11.1 Cerulean Pharma Profile
Table Cerulean Pharma Overview List
9.11.2 Cerulean Pharma Products & Services
9.11.3 Cerulean Pharma Company Dynamics & News
9.11.4 Cerulean Pharma Business Operation Conditions
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Cipla
9.12.1 Cipla Profile
Table Cipla Overview List
9.12.2 Cipla Products & Services
9.12.3 Cipla Company Dynamics & News
9.12.4 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
9.13 Cornerstone Pharmaceuticals
9.13.1 Cornerstone Pharmaceuticals Profile
Table Cornerstone Pharmaceuticals Overview List
9.13.2 Cornerstone Pharmaceuticals Products & Services
9.13.3 Cornerstone Pharmaceuticals Company Dynamics & News
9.13.4 Cornerstone Pharmaceuticals Business Operation Conditions
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Curis
9.14.1 Curis Profile
Table Curis Overview List
9.14.2 Curis Products & Services
9.14.3 Curis Company Dynamics & News
9.14.4 Curis Business Operation Conditions
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
9.15 CytRx
9.15.1 CytRx Profile
Table CytRx Overview List
9.15.2 CytRx Products & Services
9.15.3 CytRx Company Dynamics & News
9.15.4 CytRx Business Operation Conditions
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
9.16 Eli Lilly
9.16.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.16.2 Eli Lilly Products & Services
9.16.3 Eli Lilly Company Dynamics & News
9.16.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
9.17 Exelixis
9.17.1 Exelixis Profile
Table Exelixis Overview List
9.17.2 Exelixis Products & Services
9.17.3 Exelixis Company Dynamics & News
9.17.4 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
9.18 Fresenius Kabi
9.18.1 Fresenius Kabi Profile
Table Fresenius Kabi Overview List
9.18.2 Fresenius Kabi Products & Services
9.18.3 Fresenius Kabi Company Dynamics & News
9.18.4 Fresenius Kabi Business Operation Conditions
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
9.19 Genentech
9.19.1 Genentech Profile
Table Genentech Overview List
9.19.2 Genentech Products & Services
9.19.3 Genentech Company Dynamics & News
9.19.4 Genentech Business Operation Conditions
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
9.20 Hikma Pharmaceuticals
9.20.1 Hikma Pharmaceuticals Profile
Table Hikma Pharmaceuticals Overview List
9.20.2 Hikma Pharmaceuticals Products & Services
9.20.3 Hikma Pharmaceuticals Company Dynamics & News
9.20.4 Hikma Pharmaceuticals Business Operation Conditions
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.21 Hospira
9.21.1 Hospira Profile
Table Hospira Overview List
9.21.2 Hospira Products & Services
9.21.3 Hospira Company Dynamics & News
9.21.4 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
9.22 Intas Pharmaceuticals
9.22.1 Intas Pharmaceuticals Profile
Table Intas Pharmaceuticals Overview List
9.22.2 Intas Pharmaceuticals Products & Services
9.22.4 Intas Pharmaceuticals Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.23 Karyopharm Therapeutics
9.23.1 Karyopharm Therapeutics Profile
Table Karyopharm Therapeutics Overview List
9.23.2 Karyopharm Therapeutics Products & Services
9.23.3 Karyopharm Therapeutics Company Dynamics & News
9.23.4 Karyopharm Therapeutics Business Operation Conditions
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
9.24 Kyowa Hakko Kirin
9.24.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
9.24.2 Kyowa Hakko Kirin Products & Services
9.24.3 Kyowa Hakko Kirin Company Dynamics & News
9.24.4 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
9.25 Ligand Pharmaceuticals
9.25.1 Ligand Pharmaceuticals Profile
Table Ligand Pharmaceuticals Overview List
9.25.2 Ligand Pharmaceuticals Products & Services
9.25.3 Ligand Pharmaceuticals Company Dynamics & News
9.25.4 Ligand Pharmaceuticals Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure America Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Asia Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Africa Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Drugs for Non-small Cell Lung Cancer INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Drugs for Non-small Cell Lung Cancer INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Menarini Overview List
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ziopharm Oncology Overview List
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alchemia Overview List
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Pharmaceutical Overview List
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue,

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs